| 2933.99.17 | 00 | Insecticides | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 15.4¡é/kg + 64.5% |
| 2933.99.42 | 00 | Anti-infective agents: | | | | |
| 2933.99.55 | | Drugs primarily affecting the central nervous system: | | | | |
| 2933.99.79 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P) 2.9% (SG) | 15.4¡é/kg + 52% |
| 2934.10 | | Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure: | | | | |
| 2934.10.10 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 2.9% (SG) | 15.4¡é/kg + 52% |
| 2934.10.70 | 00 | 4,5-Dichloro-2-n-octyl-4-isothiazolin-3-one; Ethyl 2-(2-aminothiazol-4-yl)-2- hydroxyiminoacetate; Ethyl 2-(2-aminothiazol-4-yl)-2- methoxyiminoacetate; 2-Methyl-4-isothiazolin- 3-one; 2-n-Octyl-4-isothiazolin-3-one; and Thiothiamine hydrochloride | kg | Free | | 30.5% |
| 2934.20 | | Compounds containing in the structure a benzothiazole ring-system (whether or not hydrogenated), not further fused: | | | | |
| 2934.20.40 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P) 2.9% (SG) | 15.4¡é/kg + 52% |
| 2934.30 | | Compounds containing in the structure a phenothiazine ring-system (whether or not hydrogenated), not further fused: | | | | |
| 2934.30.43 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 2.9% (SG) | 15.4¡é/kg + 52% |
| 2934.99.16 | 00 | Insecticides | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 15.4¡é/kg + 64.5% |
| 2934.99.39 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P) 2.9% (SG) | 15.4¡é/kg + 52% |
| 2934.99.70 | 00 | Morpholinoethyl chloride hydrochloride; 2-Methyl-2,5-dioxo-1-oxa-2-phospholan; and (6R-trans)-7-Amino-3-methyl-8-oxo-5- thia-1-azabicyclo[4.2.0]-oct-2-ene-2- carboxylic acid | kg | Free | | 30.5% |
| 2935.00.29 | 00 | Anti-infective agents: | | | | |
| 2935.00.75 | 00 | Products described in additional U.S. note 3 to section VI | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P) 2.9% (SG) | 15.4¡é/kg + 57.5% |
| 2936.25.00 | 00 | Vitamin B6 (Pyridoxine and related compounds with Vitamin B6 activity) and its derivatives | kg | Free | | 25% |
| 2936.26.00 | 00 | Vitamin B12 (Cyanocobalamin and related compounds with Vitamin B12 activity) and its derivatives | kg | Free | | 15.4¡é/kg + 145.5% |
| 2936.28.00 | 00 | Vitamin E (Tocopherols and related compounds with Vitamin E activity) and its derivatives | kg | Free | | 15.4¡é/kg + 63.5% |
| 2937 | | Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: | | | | |
| 2937.11.00 | 00 | Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: | | | | |
| 2937.11.00 | 00 | Somatotropin, its derivatives and structural analogues | g | Free | | 10% |
| 2937.21.00 | | Steroidal hormones, their derivatives and structural analogues: | | | | |
| 2937.23.10 | | Obtained directly or indirectly from animal or vegetable materials | | Free | | 25% |
| 2937.31.00 | 00 | Catecholamine hormones, their derivatives and structural analogues: | | | | |
